Norpace CR is a Type 1 antiarrhythmic drug indicated for the treatment of documented ventricular arrhythmias. Pfizer has issued an update regarding the availability of Norpace CR (disopyramide ...
Patients with ventricular tachycardia and ischemic cardiomyopathy are at high risk for adverse outcomes. Catheter ablation is commonly used when antiarrhythmic drugs do not suppress ventricular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results